← Research & Industry News
External source
In Vivo CRISPR Base Editing of ANGPTL3 for Durable Lipid Lowering
Reported by Nature. Follow the link to read the original article.
- Published by
- Nature
- Evidence type
- Animal
Reported by Nature. Follow the link to read the original article.
This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at Nature.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.